Using the Modified 5-item Frailty Index to Predict Complications after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

被引：0
|
作者：
Barakat, Philipp [1 ]
Gushchin, Vadim [2 ]
King, Mary Caitlin [1 ]
Nikiforchin, Andrei [1 ]
Zuniga, Luis Felipe Falla [1 ]
Lopez-Ramirez, Felipe [1 ]
Nieroda, Carol [1 ]
Sardi, Armando [3 ]
机构：
[1] Mercy Med Ctr, Baltimore, MD USA
[2] Mercy Med Ctr, Program Mercy, Baltimore, MD USA
[3] Mercy Med Ctr, Inst Canc Care, Baltimore, MD USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E340
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [11] A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Baumgartner, Joel M.
    Kwong, Thomas G.
    Ma, Grace L.
    Messer, Karen
    Kelly, Kaitlyn J.
    Lowy, Andrew M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) : 1609 - 1617
  • [12] Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Ioannis T. Konstantinidis
    Konstantinos Chouliaras
    Edward A. Levine
    Byrne Lee
    Konstantinos I. Votanopoulos
    Annals of Surgical Oncology, 2017, 24 : 3825 - 3830
  • [13] Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Konstantinidis, Ioannis T.
    Chouliaras, Konstantinos
    Levine, Edward A.
    Lee, Byrne
    Votanopoulos, Konstantinos I.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 3825 - 3830
  • [14] Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Oliver S. Eng
    Sinziana Dumitra
    Michael O’Leary
    Mark Wakabayashi
    Thanh H. Dellinger
    Ernest S. Han
    Stephen J. Lee
    I. Benjamin Paz
    Gagandeep Singh
    Byrne Lee
    Annals of Surgical Oncology, 2017, 24 : 2707 - 2711
  • [15] Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Eng, Oliver S.
    Dumitra, Sinziana
    O'Leary, Michael
    Wakabayashi, Mark
    Dellinger, Thanh H.
    Han, Ernest S.
    Lee, Stephen J.
    Paz, I. Benjamin
    Singh, Gagandeep
    Lee, Byrne
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2707 - 2711
  • [16] Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Pintado, Maria Consuelo
    Unzue, Inmaculada Lasa
    Sanz, Remedios Gomez
    Alonso, Manuel Diez
    Ortega, Miguel A.
    de Mon, Melchor Alvarez
    Losada, Emilio Nevado
    Calvo, Alberto Gutierrez
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [17] Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
    Gani, Faiz
    Conca-Cheng, Alison M.
    Nettles, Brenda
    Ahuja, Nita
    Johnston, Fabian M.
    JOURNAL OF SURGICAL RESEARCH, 2019, 234 : 240 - 248
  • [18] Predictors of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Paredes, Anghela Z.
    Abdel-Misih, Sherif
    Schmidt, Carl
    Dillhoff, Mary E.
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    JOURNAL OF SURGICAL RESEARCH, 2019, 234 : 103 - 109
  • [19] Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
    Scally, Christopher P.
    Fournier, Keith F.
    Mansfield, Paul F.
    JAMA SURGERY, 2021, 156 (03)
  • [20] Impact of Major Complications on Patients’ Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Trevor D. Hamilton
    Emily L. Taylor
    Amanda J. Cannell
    J. Andrea McCart
    Anand Govindarajan
    Annals of Surgical Oncology, 2016, 23 : 2946 - 2952
12345